Arcutis Biotherapeutics

$26.98
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.

-$1.23 (-4.36%) As of 3:34 PM UTC today

Why Robinhood?

You can buy or sell ARQT and other stocks, options, and ETFs commission-free!

About ARQT

Arcutis Biotherapeutics, Inc. engages in the development and commercialization of treatments for dermatological diseases. Its piepline consists of topical treatments for plaque psoriasis, atopic dermatitis, eczema, vitiligo, alopecia areata, and seborrheic dermatitis. The company was founded by Bhaskar Chaudhuri and David W. Osborne on June 1, 2016 and is headquartered in Westlake Village, CA. The listed name for ARQT is Arcutis Biotherapeutics, Inc. Common Stock.

CEO
Todd Franklin Watanabe
Employees
29
Headquarters
Westlake Village, California
Founded
—
Market Cap
1.16B
Price-Earnings Ratio
—
Dividend Yield
—
Average Volume
114.43K
High Today
$28.32
Low Today
$26.71
Open Price
$28.32
Volume
21.27K
52 Week High
$40.88
52 Week Low
$17.10

Collections

ARQT Earnings

-$1.15
-$0.77
-$0.38
$0.00
Q1 FY20
Q2 FY20
Q3 FY20
Q4 FY20
Estimated
— per share
Actual
Expected Feb 25, After Hours

You May Also Like

INAQU
All investments involve risks, including the loss of principal. Securities trading offered through Robinhood Financial LLC, a registered broker-dealer and Member SIPC. Full disclosure